An Independent Pharmacy Federation survey has highlighted problems in obtaining supplies of leading medications from several pharmaceutical majors.
Eli Lilly, Pfizer and Sanofi were all named in the survey, which included the opinion of more than 500 independent pharmacists.
Go deeper with GlobalData
Eli Lilly was indentified as being the most problematic by 27% of those questioned, whereas 13% and 12% highlighted problems with Sanofi and Pfizer respectively.
Of those questioned, 50% said that they could spend up to three hours a week attempting to obtain supplies from alternative sources and 29% claimed that in excess of ten patients had been affected by drug shortages.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
